Author/Creator: Zheng, Xiaowei - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Zheng, Xiaowei

11. CONFIGURING A CONSTITUTIONAL STATE: OFFICIALS AND ASSEMBLYMEN AT THE 1909 SICHUAN PROVINCIAL ASSEMBLY MEETING. (October 2013)

Authors:: Zheng, Xiaowei
Journal:: Twentieth-century China
Issue:: Volume 38:Number 3(2013)
Page Start:: 230
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

12. Contrasting summer versus winter dynamic microbial communities and their environmental driving factors in the solid-state saccharification process of Fuyu-flavor Baijiu. (April 2022)

Authors:: Kang, Jiamu; Zheng, Xiaowei; Yang, Xin; Li, Haoran; Cheng, Jun; Fan, Lin; Zhao, Hu; Xue, Yansong; Ding, Ziyuan; Han, Beizhong
Journal:: Food research international
Issue:: Volume 154(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

13. Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma. (2nd January 2018)

Authors:: Chen, Siying; Meng, Ti; Zheng, Xiaowei; Cai, Jiangxia; Zhang, Weipeng; You, Haisheng; Xing, Jianfeng; Dong, Yalin
Journal:: Journal of drug targeting
Issue:: Volume 26:Number 1(2018)
Page Start:: 27
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

14. Corrigendum to "Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy". (26th May 2021)

Authors:: Ekberg, Neda Rajamand; Eliasson, Sofie; Li, Young Wen; Zheng, Xiaowei; Chatzidionysiou, Katerina; Falhammar, Henrik; Gu, Harvest F.; Catrina, Sergiu-Bogdan
Journal:: Journal of diabetes research
Issue:: Volume 2021(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

15. Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. Issue 12 (18th December 2020)

Authors:: Xin, Wenxiu; Ding, Haiying; Fang, Qilu; Zheng, Xiaowei; Tong, Yinghui; Xu, Gaoqi; Yang, Guonong
Journal:: BMJ open
Issue:: Volume 10:Issue 12(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

16. Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. Issue 12 (18th December 2020)

Authors:: Xin, Wenxiu; Ding, Haiying; Fang, Qilu; Zheng, Xiaowei; Tong, Yinghui; Xu, Gaoqi; Yang, Guonong
Journal:: BMJ open
Issue:: Volume 10:Issue 12(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

17. Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. Issue 12 (18th December 2020)

Authors:: Xin, Wenxiu; Ding, Haiying; Fang, Qilu; Zheng, Xiaowei; Tong, Yinghui; Xu, Gaoqi; Yang, Guonong
Journal:: BMJ open
Issue:: Volume 10:Issue 12(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

18. Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. Issue 12 (18th December 2020)

Authors:: Xin, Wenxiu; Ding, Haiying; Fang, Qilu; Zheng, Xiaowei; Tong, Yinghui; Xu, Gaoqi; Yang, Guonong
Journal:: BMJ open
Issue:: Volume 10:Issue 12(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

19. Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. Issue 12 (18th December 2020)

Authors:: Xin, Wenxiu; Ding, Haiying; Fang, Qilu; Zheng, Xiaowei; Tong, Yinghui; Xu, Gaoqi; Yang, Guonong
Journal:: BMJ open
Issue:: Volume 10:Issue 12(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

20. Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. Issue 12 (18th December 2020)

Authors:: Xin, Wenxiu; Ding, Haiying; Fang, Qilu; Zheng, Xiaowei; Tong, Yinghui; Xu, Gaoqi; Yang, Guonong
Journal:: BMJ open
Issue:: Volume 10:Issue 12(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗